We are live on ! Find out more
BMY icon

Bristol-Myers Squibb

2,447 hedge funds and large institutions have $100B invested in Bristol-Myers Squibb in 2021 Q4 according to their latest regulatory filings, with 328 funds opening new positions, 863 increasing their positions, 1,010 reducing their positions, and 137 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more first-time investments, than exits

New positions opened: 328 | Existing positions closed: 137

29% more call options, than puts

Call options by funds: $2B | Put options by funds: $1.56B

7% more funds holding

Funds holding: 2,296 → 2,447 (+151)

0% more funds holding in top 10

Funds holding in top 10: 64 → 64 (0)

1.15% less ownership

Funds ownership: 73.47% → 72.32% (-1.1%)

15% less repeat investments, than reductions

Existing positions increased: 863 | Existing positions reduced: 1,010

23% less capital inflows, than outflows

Capital inflows: $4.89B | Capital outflows: $6.38B

Holders
2,447
Holders Change
+151
Holders Change %
+6.58%
% of All Funds
37.51%
Holding in Top 10
64
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.98%
New
328
Increased
863
Reduced
1,010
Closed
137
Calls
$2​B
Puts
$1.56​B
Net Calls
+$447​M
Net Calls Change
+$189​M

BMY Hedge Fund Activity: Q4 2021 in Review

2,447 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q4 2021, worth a combined $100B — up 3.5% from $96.7B a quarter earlier.

Buyers outnumbered sellers: 328 funds opened new BMY positions and 137 closed out — a net gain of 191 holders — while 863 added to existing stakes and 1,010 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $362M. The largest seller was Berkshire Hathaway, cutting an estimated $988M.

  • 2,447 institutional investors held Bristol-Myers Squibb (BMY) as of Q4 2021, up from 2,296 in Q3 2021.
  • Funds reported $100B of Bristol-Myers Squibb stock for Q4 2021, up 3.5% quarter-over-quarter.
  • 328 funds opened new Bristol-Myers Squibb positions in Q4 2021 and 137 closed out, a net change of +191 holders.
  • The largest Bristol-Myers Squibb buyer in Q4 2021 was JP Morgan Chase, an estimated $362M added.
  • The largest Bristol-Myers Squibb seller in Q4 2021 was Berkshire Hathaway, an estimated $988M sold.

Based on aggregated 13F filings for Q4 2021.